Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Bate, Clive; * | Williams, Alun; 1
Affiliations: Department of Pathology and Infectious Diseases, Royal Veterinary College, Hawkshead Lane, North Mymms, Herts, UK
Correspondence: [*] Correspondence to: Dr. Clive Bate, Department of Pathology and Infectious Diseases, Royal Veterinary College, Hawkshead Lane, North Mymms, Herts AL9 7TA, UK. Tel.: +44 1707 666550; E-mail: [email protected].
Note: [1] Present address: Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.
Note: [] Handling Associate Editor: James Bamburg
Abstract: The pathogenesis of Alzheimer's disease (AD) is associated with the accumulation of amyloid-β (Aβ) peptides and the loss of synapses. The addition of Aβ1–42 reduced the amount of synaptophysin in cultured cortical neurons in a model of AD-induced synapse degeneration. Aβ1–42 also reduced the uptake of the fluorescent dye FM1-43 into synaptic recycling vesicles, a measure of synaptic function. We report that pre-mixing Aβ1–40 with Aβ1–42 significantly reduced the effects of Aβ1–42 on synapses; it increased both synaptic vesicle recycling and synaptophysin content. These results are consistent with reports that Aβ1–40 forms oligomers with Aβ1–42 and that these are less toxic than Aβ1–42 alone. In contrast, the addition of Aβ1–40 did not affect the synapse degeneration induced by the prion-derived peptide PrP82-146. The addition of Aβ1–40 reduced Aβ1–42 induced activation of cytoplasmic phospholipase A2 (cPLA2) within synapses consistent with the hypothesis that Aβ1–42 induced synapse degeneration is mediated by aberrant activation of synaptic cPLA2. Such observations raise the possibility that the amount of Aβ1–40 produced within the brain is critical in determining the synapse damaging effects of Aβ1–42 and possibly the cognitive loss seen during the early stages of AD.
Keywords: Alzheimer's disease, amyloid, oligomers, phospholipase A2, synapses, synaptophysin
DOI: 10.3233/JAD-2010-100528
Journal: Journal of Alzheimer's Disease, vol. 21, no. 3, pp. 985-993, 2010
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]